Urology · Morristown, NJ
NPI
1871593947
Since 2005
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
261 James St, Suite 3a
Morristown, NJ, 07960
Phone (973) 206-8282
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
62,590 services
Medicare patients, 2024
1,298
Average age 77
Drug cost, 2024
$15.0M
6,408 prescriptions
Company payments, 2025
$30K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David L Taylor was code J9155 (injection, degarelix, 1 mg), 27,920 times for 51 patients. In total David L Taylor billed 62,590 services in 75 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9155 Injection, degarelix, 1 mg | Office | 27,920 | 51 | $3.30 | $92K |
| J0897 Injection, denosumab, 1 mg | Office | 27,780 | 60 | $20.60 | $572K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,238 | 951 | $13.71 | $17K |
| 81003 Clinical Chemistry | Office | 1,220 | 974 | $2.20 | $2,684 |
| 99214 Office E&M - Established | Office | 1,007 | 858 | $100.91 | $102K |
| 36415 Venipuncture Blood Collection | Office | 638 | 495 | $8.64 | $5,512 |
| 96402 Chemotherapy Administration | Office | 437 | 97 | $29.85 | $13K |
| 99215 Office E&M - Established | Office | 374 | 231 | $149.63 | $56K |
| 51798 Ultrasound - Nonspecific | Office | 341 | 289 | $9.67 | $3,296 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 339 | 47 | $140.03 | $47K |
| 96401 Chemotherapy Administration | Office | 255 | 67 | $64.70 | $16K |
| 99213 Office E&M - Established | Office | 122 | 119 | $67.15 | $8,193 |
| 99204 Office E&M - New | Office | 77 | 77 | $129.08 | $9,939 |
| 55706 Other Organ Systems | Office | 25 | 25 | $323.96 | $8,099 |
| 52000 Cystourethroscopy | Facility | 25 | 25 | $62.07 | $1,552 |
By year: 2022 $1.1M for 32,938 services; 2023 $1.2M for 52,861 services; 2024 $1.6M for 62,590 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,220 | 974 | $2.20 | $2,684 |
| 36415 Venipuncture Blood Collection | 638 | 495 | $8.64 | $5,512 |
Medicare prescription drug claims, 2024
In 2024, the drug David L Taylor prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,845 prescriptions and refills. In total David L Taylor wrote 6,408 Medicare prescriptions that cost $15.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,845 | 5,290 | 575 | $48K |
| Orgovyx Relugolix | 735 | 735 | 98 | $1.9M |
| Finasteride Generic | 621 | 1,840 | 182 | $11K |
| Erleada Apalutamide | 550 | 553 | 66 | $7.8M |
| Dutasteride Generic | 406 | 1,094 | 104 | $15K |
| Abiraterone Acetate Generic | 257 | 271 | 28 | $322K |
| Prednisone Generic | 244 | 278 | 34 | $1,642 |
| Nubeqa Darolutamide | 208 | 208 | 35 | $2.7M |
| Xtandi Enzalutamide | 140 | 140 | 18 | $1.9M |
| Methenamine Hippurate Generic | 137 | 359 | 47 | $14K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 136 | 376 | 41 | $3,537 |
| Potassium Citrate Er Potassium Citrate | 133 | 330 | 36 | $12K |
| Myrbetriq Mirabegron | 128 | 296 | 46 | $127K |
| Solifenacin Succinate Generic | 87 | 179 | 21 | $3,191 |
| Gemtesa Vibegron | 87 | 157 | 29 | $75K |
Brand drugs: 1,935 claims; generic drugs: 4,473 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David L Taylor $30K ($30K in general payments such as food, travel and fees) from 26 companies. The largest payer was Janssen Biotech, Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 37 | $16K |
| Progenics Pharmaceuticals, Inc. | 10 | $5,286 |
| Avyxa Pharma, LLC | 7 | $3,799 |
| Immunitybio, Inc. IBRX | 3 | $2,801 |
| Ferring Pharmaceuticals Inc. | 1 | $1,012 |
| Calyxo, Inc. | 2 | $295 |
| Telix Pharmaceuticals TLX | 5 | $225 |
| Dendreon Pharmaceuticals LLC | 5 | $171 |
| Pfizer Inc. PFE | 8 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $151 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.